tesaglitazar: Clinical Trials

4 trials of tesaglitazar, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated, 1 completed. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Terminated 3, Completed 1

Follow tesaglitazar: new trials by email Literature Review of tesaglitazar trials Research Report on tesaglitazar

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin Sensitivity
Tesaglitazar, Metformin, Dietary and lifestyle modification counseling - Type 2 Diabetes
Phase 2TerminatedAstraZeneca1052005-08-012008-03-17
ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR)
Tesaglitazar, pioglitazone - Diabetes Mellitus, Type 2
Phase 2TerminatedAstraZeneca1002004-09-012011-08-30
Dose Response Study in Japanese Patients
Tesaglitazar - Type 2 Diabetes
Phase 2TerminatedAstraZeneca2502004-05-012009-04-22
GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes
Tesaglitazar, Pioglitazone, Dietary and Lifestyle Modification Counseling - Type 2 Diabetes
Phase 2CompletedAstraZeneca5002002-04-012006-07-31

Conditions studied

Diabetes Mellitus, Type 2 (4)

Sponsors

AstraZeneca (4)

Countries

United States (2)  ·  Canada (1)  ·  Finland (1)  ·  France (1)  ·  Italy (1)  ·  Japan (1)  ·  Mexico (1)  ·  United Kingdom (1)

Results publications

PMID 17166340